Search results for multiple sclerosis

“Similarly, photoreceptors in the eyes respond to UV exposure, modulating the regulation of circadian rhythms. Findings from a new study suggest that early life exposure to ultraviolet light reduces the risk of developing early-onset multiple sclerosis (MS).”

“Antibodies that destroy myelin in multiple sclerosis may cross-react with casein, a milk protein. Multiple sclerosis (MS) is a neurodegenerative and autoimmune disease caused when the immune system attacks myelin proteins on nerves, mistaking them for proteins produced by pathogens.”

“Multiple sclerosis patients also displayed a decrease in a type of immune cell called myeloid-derived dendritic cells which play a role in suppressing immune cells that prevent autoimmunity (called T-regulatory cells).”

“This is strong genetic evidence that suggests vitamin D supplementation may significantly lower risk of multiple sclerosis.”

“This is a much higher dose than the Institute of Medicine recommends as the daily upper tolerable intake (10,000 IU per day). People with multiple sclerosis have been shown to have SNPs that affect vitamin D metabolism.”

“Resistance training (twice a week for 6 months) slowed brain shrinkage in multiple sclerosis (MS) patients and even led to brain growth in other areas of the brain. This is the first time that resistance training has been shown to prevent brain atrophy in MS patients.”

“Multiple sclerosis has also been linked to genetically low vitamin D...meaning a gene that converts vitamin D into active vitamin D hormone does not work well in many MS patients so they need an unusually high dose of vitamin D.”

“FTA: > Persons with multiple sclerosis who smoked for a little as six months during their lifetime had more destruction of brain tissue and more brain atrophy than MS patients who never smoked, a study by neuroimaging specialists at the University at Buffalo has shown.”

“Intermittent fasting (every other day) increased gut bacteria diversity and reduced inflammation, demyelination, and axonal damage in multiple sclerosis (MS) animal model. A small pilot trial in humans with MS showed many similar changes to the gut microbiome and blood adipokines such as leptin.”

“Multiple sclerosis Preclinical evidence suggests that berberine shows promise in treating the clinical symptoms associated with multiple sclerosis, or MS, a type of autoimmune disease that affects the central nervous system.”